Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
life sciences
national blog main
boston
clinical trials
drugs
new york blog main
new york top stories
san francisco blog main
san francisco top stories
accelerated approval
acute hepatic porphyria
alnylam pharmaceuticals
aminolevulinic acid
biontech
blueprint medicines
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer
companion diagnostic
curevac
deals
detroit blog main
detroit top stories
dna sequencing
eli lilly
entrectinib
express scripts
fda
foundation medicine
givosiran
indiana blog main
indiana top stories
infectious diseases
john shiver
josh bilenker
keytruda
larotrectinib
What
new
3
×
second
3
×
cancer
drug
medicine
rna
time
alnylam
approved
bets
bio
cleared
comes
companies
cut
data
date
deal
deeper
dna
effective
enticed
evidence
far
fda
fingerprint
genetic
going
hasn’t
interference
latest
market
matter
medicines
messenger
molecules
mrna
multiple
nasdaq
nd
Language
Current search:
new
×
" boston top stories "
×
second
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines